JAZZ PHARMACEUTICALS INC 4
4 · JAZZ PHARMACEUTICALS INC · Filed Jun 2, 2008
Insider Transaction Report
Form 4
Wissel Janne LT
SVP, Chief Regulatory Officer
Transactions
- Other
Common Stock
2008-05-30$6.50/sh+1,278$8,307→ 104,000 total
Footnotes (1)
- [F1]Shares acquired through a qualified Section 423 Employee Stock Purchase Plan.